{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:26:31Z","timestamp":1784953591617,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T00:00:00Z","timestamp":1235692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1475-2875-8-35","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T19:14:39Z","timestamp":1235762079000},"source":"Crossref","is-referenced-by-count":13,"title":["AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5"],"prefix":"10.1186","volume":"8","author":[{"given":"Gustavo","family":"Bracho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"Zayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Coppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,27]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1073\/pnas.97.13.6994","volume":"97","author":"SM Rich","year":"2000","unstructured":"Rich SM, Ayala FJ: Population structure and recent evolution of Plasmodium falciparum. Proc Natl Acad Sci USA. 2000, 97: 6994-7001.","journal-title":"Proc Natl Acad Sci USA"},{"key":"784_CR2","first-page":"CD000129","volume-title":"Cochrane Database Syst Rev","author":"P Graves","year":"2003","unstructured":"Graves P, Gelband H: Vaccines for preventing malaria. Cochrane Database Syst Rev. 2003, CD000129-"},{"key":"784_CR3","first-page":"CD005966","volume-title":"Cochrane Database Syst Rev","author":"P Graves","year":"2006","unstructured":"Graves P, Gelband H: Vaccines for preventing malaria (SPf66). Cochrane Database Syst Rev. 2006, CD005966-"},{"key":"784_CR4","first-page":"94","volume":"82","author":"R Lasserre","year":"1989","unstructured":"Lasserre R: [The treatment of multiresistant falciparum malaria in Southeast Asia]. Bull Soc Pathol Exot Filiales. 1989, 82: 94-100.","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"784_CR5","first-page":"CD003755","volume-title":"Cochrane Database Syst Rev","author":"C Gamble","year":"2006","unstructured":"Gamble C, Ekwaru JP, ter Kuile FO: Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev. 2006, CD003755-"},{"key":"784_CR6","first-page":"409","volume":"41","author":"AA Holder","year":"1999","unstructured":"Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ: Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia. 1999, 41: 409-14.","journal-title":"Parassitologia"},{"issue":"Suppl 3","key":"784_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1590\/S0074-02761992000700004","volume":"87","author":"AA Holder","year":"1992","unstructured":"Holder AA, Blackman MJ, Burghaus PA, Chappel JA, Ling IT, McCallum-Deighton N, Shai S: A malaria merozoite surface protein (MSP1)-structure, processing and function. Mem Inst Oswaldo Cruz. 1992, 87 (Suppl 3): 37-42.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"784_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0166-6851(01)00265-1","volume":"114","author":"CG Black","year":"2001","unstructured":"Black CG, Wu T, Wang L, Hibbs AR, Coppel RL: Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains. Mol Biochem Parasitol. 2001, 114: 217-26.","journal-title":"Mol Biochem Parasitol"},{"key":"784_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(98)00045-0","volume":"94","author":"VM Marshall","year":"1998","unstructured":"Marshall VM, Tieqiao W, Coppel RL: Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum. Mol Biochem Parasitol. 1998, 94: 13-25.","journal-title":"Mol Biochem Parasitol"},{"key":"784_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/IAI.66.1.239-246.1998","volume":"66","author":"D Eisen","year":"1998","unstructured":"Eisen D, Billman-Jacobe H, Marshall VF, Fryauff D, Coppel RL: Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect Immun. 1998, 66: 239-46.","journal-title":"Infect Immun"},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1016\/j.vaccine.2005.06.030","volume":"24","author":"SD Polley","year":"2006","unstructured":"Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K: High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine. 2006, 24: 4233-46.","journal-title":"Vaccine"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1128\/IAI.69.7.4390-4397.2001","volume":"69","author":"L Wang","year":"2001","unstructured":"Wang L, Richie TL, Stowers A, Nhan DH, Coppel RL: Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. Infect Immun. 2001, 69: 4390-7.","journal-title":"Infect Immun"},{"key":"784_CR13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/IAI.67.5.2193-2200.1999","volume":"67","author":"L Wang","year":"1999","unstructured":"Wang L, Black CG, Marshall VM, Coppel RL: Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect Immun. 1999, 67: 2193-200.","journal-title":"Infect Immun"},{"key":"784_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0166-6851(02)00308-0","volume":"127","author":"CG Black","year":"2003","unstructured":"Black CG, Wang L, Wu T, Coppel RL: Apical location of a novel EGF-like domain-containing protein of Plasmodium falciparum. Mol Biochem Parasitol. 2003, 127: 59-68.","journal-title":"Mol Biochem Parasitol"},{"key":"784_CR15","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1128\/IAI.65.11.4460-4467.1997","volume":"65","author":"VM Marshall","year":"1997","unstructured":"Marshall VM, Silva A, Foley M, Cranmer S, Wang L, McColl DJ, Kemp DJ, Coppel RL: A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain. Infect Immun. 1997, 65: 4460-7.","journal-title":"Infect Immun"},{"key":"784_CR16","first-page":"429","volume":"48","author":"RC Mahajan","year":"2005","unstructured":"Mahajan RC, Farooq U, Dubey ML, Malla N: Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens. Indian J Pathol Microbiol. 2005, 48: 429-38.","journal-title":"Indian J Pathol Microbiol"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0166-6851(99)00134-6","volume":"103","author":"T Wu","year":"1999","unstructured":"Wu T, Black CG, Wang L, Hibbs AR, Coppel RL: Lack of sequence diversity in the gene encoding merozoite surface protein 5 of Plasmodium falciparum. Mol Biochem Parasitol. 1999, 103: 243-50.","journal-title":"Mol Biochem Parasitol"},{"key":"784_CR18","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/IAI.64.7.2602-2608.1996","volume":"64","author":"TM Daly","year":"1996","unstructured":"Daly TM, Long CA: Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect Immun. 1996, 64: 2602-8.","journal-title":"Infect Immun"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm975","volume":"10","author":"H Hisaeda","year":"2004","unstructured":"Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno K, Kishihara K, Tsukumo S, Yasutomo K: Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells. Nat Med. 2004, 10: 29-30.","journal-title":"Nat Med"},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2005.08.006","volume":"23","author":"M Walther","year":"2005","unstructured":"Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ: Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 2005, 23: 287-96.","journal-title":"Immunity"},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-3024.2006.00775.x","volume":"28","author":"EM Riley","year":"2006","unstructured":"Riley EM, Wahl S, Perkins DJ, Schofield L: Regulating immunity to malaria. Parasite Immunol. 2006, 28: 35-49.","journal-title":"Parasite Immunol"},{"key":"784_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd1176","volume":"2","author":"DT O'Hagan","year":"2003","unstructured":"O'Hagan DT, Valiante NM: Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov. 2003, 2: 727-35.","journal-title":"Nat Rev Drug Discov"},{"key":"784_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3156.2006.01754.x","volume":"12","author":"E Macete","year":"2007","unstructured":"Macete E, Aponte JJ, Guinovart C, Sacarlal J, Ofori-Anyinam O, Mandomando I, Espasa M, Bevilacqua C, Leach A, Dubois MC: Safety and immunogenicity of the RTS,S\/AS02A candidate malaria vaccine in children aged 1\u20134 in Mozambique. Trop Med Int Health. 2007, 12: 37-46.","journal-title":"Trop Med Int Health"},{"key":"784_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1745-6215-8-11","volume":"8","author":"EV Macete","year":"2007","unstructured":"Macete EV, Sacarlal J, Aponte JJ, Leach A, Navia MM, Milman J, Guinovart C, Mandomando I, Lopez-Pua Y, Lievens M: Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I\/IIb randomized double-blind bridging trial. Trials. 2007, 8: 11-","journal-title":"Trials"},{"key":"784_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1586\/14760584.2.2.231","volume":"2","author":"N Garcon","year":"2003","unstructured":"Garcon N, Heppner DG, Cohen J: Development of RTS,S\/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant. Expert Rev Vaccines. 2003, 2: 231-8.","journal-title":"Expert Rev Vaccines"},{"key":"784_CR26","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1016\/j.vaccine.2006.01.005","volume":"24","author":"BK Giersing","year":"2006","unstructured":"Giersing BK, Dubovsky F, Saul A, Denamur F, Minor P, Meade B: Potency assay design for adjuvanted recombinant proteins as malaria vaccines. Vaccine. 2006, 24: 4264-70.","journal-title":"Vaccine"},{"key":"784_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/156652406776055221","volume":"6","author":"L Schofield","year":"2006","unstructured":"Schofield L, Mueller I: Clinical immunity to malaria. Curr Mol Med. 2006, 6: 205-21.","journal-title":"Curr Mol Med"},{"key":"784_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000058841","volume":"80","author":"MR Hollingdale","year":"2002","unstructured":"Hollingdale MR, Krzych U: Immune responses to liver-stage parasites: implications for vaccine development. Chem Immunol. 2002, 80: 97-124.","journal-title":"Chem Immunol"},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri1746","volume":"6","author":"AV Hill","year":"2006","unstructured":"Hill AV: Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol. 2006, 6: 21-32.","journal-title":"Nat Rev Immunol"},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/IAI.74.5.2887-2893.2006","volume":"74","author":"M Pinder","year":"2006","unstructured":"Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P: Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children. Infect Immun. 2006, 74: 2887-93.","journal-title":"Infect Immun"},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0166-6851(99)00178-4","volume":"105","author":"L Kedzierski","year":"2000","unstructured":"Kedzierski L, Black CG, Coppel RL: Characterization of the merozoite surface protein 4\/5 gene of Plasmodium berghei and Plasmodiumyoelii. Mol Biochem Parasitol. 2000, 105: 137-47.","journal-title":"Mol Biochem Parasitol"},{"key":"784_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1440-1711.2004.01293.x","volume":"82","author":"O Perez","year":"2004","unstructured":"Perez O, Bracho G, Lastre M, Mora N, del Campo J, Gil D, Zayas C, Acevedo R, Gonzalez D, Lopez JA: Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern. Immunol Cell Biol. 2004, 82: 603-10.","journal-title":"Immunol Cell Biol"},{"issue":"Suppl 2","key":"784_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.vaccine.2005.01.139","volume":"24","author":"C Zayas","year":"2006","unstructured":"Zayas C, Bracho G, Lastre M, Gonzalez D, Gil D, Acevedo R, del Campo J, Taboada C, Solis RL, Barbera R: Scale up of proteoliposome derived Cochleate production. Vaccine. 2006, 24 (Suppl 2): 94-5.","journal-title":"Vaccine"},{"key":"784_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0169-409X(98)00014-3","volume":"32","author":"RJ Mannino","year":"1998","unstructured":"Mannino RJ, Canki M, Feketeova E, Scolpino AJ, Wang Z, Zhang F, Kheiri MT, Gould-Fogerite S: Targeting immune response induction with cochleate and liposome-based vaccines. Adv Drug Deliv Rev. 1998, 32: 273-287.","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 2","key":"784_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.vaccine.2005.01.108","volume":"24","author":"G Bracho","year":"2006","unstructured":"Bracho G, Lastre M, del Campo J, Zayas C, Gonzalez D, Gil D, Acevedo R, Taboada C, Solis RL, Perez O: Proteoliposome derived cochleate as novel adjuvant. Vaccine. 2006, 24 (Suppl 2): 30-1.","journal-title":"Vaccine"},{"key":"784_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-3083.2007.01981.x","volume":"66","author":"O Perez","year":"2007","unstructured":"Perez O, Lastre M, Cabrera O, del Campo K, Bracho G, Cuello M, Balboa J, Acevedo R, Zayas C, Gil D: New vaccines require potent adjuvants like AFPL1 and AFCo1. Scand J Immunol. 2007, 66: 271-7.","journal-title":"Scand J Immunol"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.vaccine.2005.01.119","volume":"24 Suppl 2","author":"J del Campo","year":"2006","unstructured":"del Campo J, Lastre M, Bracho G, Rodriguez T, Gil D, Zayas C, Taboada C, Acevedo R, Perez DR, Perez O: Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants. Vaccine. 2006, 24 Suppl 2: 50-51.","journal-title":"Vaccine"},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1016\/j.vaccine.2006.06.035","volume":"24","author":"VA Stewart","year":"2006","unstructured":"Stewart VA, Walsh DS, McGrath SM, Kester KE, Cummings JF, Voss G, Delchambre M, Garcon N, Cohen JD, Heppner DG: Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine. 2006, 24: 6493-502.","journal-title":"Vaccine"},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","volume":"24","author":"VA Stewart","year":"2006","unstructured":"Stewart VA, McGrath SM, Walsh DS, Davis S, Hess AS, Ware LA, Kester KE, Cummings JF, Burge JR, Voss G: Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S\/AS02A. Vaccine. 2006, 24: 6483-92.","journal-title":"Vaccine"},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ijpara.2004.10.001","volume":"34","author":"A Morrot","year":"2004","unstructured":"Morrot A, Zavala F: Regulation of the CD8+ T cell responses against Plasmodium liver stages in mice. Int J Parasitol. 2004, 34: 1529-34.","journal-title":"Int J Parasitol"},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-3083.2007.01909.x","volume":"65","author":"S Basta","year":"2007","unstructured":"Basta S, Alatery A: The cross-priming pathway: a portrait of an intricate immune system. Scand J Immunol. 2007, 65: 311-9.","journal-title":"Scand J Immunol"},{"key":"784_CR42","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/IAI.01679-05","volume":"74","author":"S Singh","year":"2006","unstructured":"Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA: Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect Immun. 2006, 74: 4573-80.","journal-title":"Infect Immun"},{"key":"784_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/156652406776055212","volume":"6","author":"SS Yazdani","year":"2006","unstructured":"Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE: Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med. 2006, 6: 187-203.","journal-title":"Curr Mol Med"},{"key":"784_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2005.08.011","volume":"23","author":"MF Good","year":"2005","unstructured":"Good MF: Identification of early cellular immune factors regulating growth of malaria parasites in humans. Immunity. 2005, 23: 241-2.","journal-title":"Immunity"},{"key":"784_CR45","first-page":"210","volume":"46","author":"P Perlmann","year":"2000","unstructured":"Perlmann P, Troye-Blomberg M: Malaria blood-stage infection and its control by the immune system. Folia Biol (Praha). 2000, 46: 210-8.","journal-title":"Folia Biol (Praha)"},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.vaccine.2007.12.018","volume":"26","author":"P Mettens","year":"2008","unstructured":"Mettens P, Dubois PM, Demoitie MA, Bayat B, Donner MN, Bourguignon P, Stewart VA, Heppner DG, Garcon N, Cohen J: Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine. 2008, 26: 1072-82.","journal-title":"Vaccine"},{"key":"784_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-065X.2007.00501.x","volume":"216","author":"J Stark","year":"2007","unstructured":"Stark J, Chan C, George AJ: Oscillations in the immune system. Immunol Rev. 2007, 216: 213-31.","journal-title":"Immunol Rev"},{"key":"784_CR48","doi-asserted-by":"publisher","first-page":"18243","DOI":"10.1073\/pnas.0608545103","volume":"103","author":"Y Wu","year":"2006","unstructured":"Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y: Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci USA. 2006, 103: 18243-8.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"784_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vaccine.2005.01.104","volume":"24","author":"G Dougan","year":"2006","unstructured":"Dougan G, Hormaeche C: How bacteria and their products provide clues to vaccine and adjuvant development. Vaccine. 2006, 24 (Suppl 2): 13-9.","journal-title":"Vaccine"},{"key":"784_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000090001","volume":"139","author":"M Schnare","year":"2006","unstructured":"Schnare M, Rollinghoff M, Qureshi S: Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol. 2006, 139: 75-85.","journal-title":"Int Arch Allergy Immunol"},{"key":"784_CR51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni1223","volume":"6","author":"G Napolitani","year":"2005","unstructured":"Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A: Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005, 6: 769-76.","journal-title":"Nat Immunol"},{"key":"784_CR52","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/IAI.67.5.2075-2081.1999","volume":"67","author":"CG Black","year":"1999","unstructured":"Black CG, Wang L, Hibbs AR, Werner E, Coppel RL: Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum. Infect Immun. 1999, 67: 2075-81.","journal-title":"Infect Immun"},{"key":"784_CR53","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1128\/IAI.72.10.5840-5849.2004","volume":"72","author":"MW Goschnick","year":"2004","unstructured":"Goschnick MW, Black CG, Kedzierski L, Holder AA, Coppel RL: Merozoite surface protein 4\/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect Immun. 2004, 72: 5840-9.","journal-title":"Infect Immun"},{"key":"784_CR54","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1128\/IAI.70.12.6606-6613.2002","volume":"70","author":"L Kedzierski","year":"2002","unstructured":"Kedzierski L, Black CG, Goschnick MW, Stowers AW, Coppel RL: Immunization with a combination of merozoite surface proteins 4\/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infect Immun. 2002, 70: 6606-13.","journal-title":"Infect Immun"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-8-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-8-35\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-8-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T23:49:55Z","timestamp":1710114595000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-8-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,27]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-8-35","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,27]]},"article-number":"35"}}